We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Avis
CAR
$5.19B
| $2.96M | 0.01% |
49,526
+49,381
| +34,056% | +$2.71M |
|
|
COL
502
DELISTED
Rockwell Collins
COL
| $2.94M | 0.01% |
37,694
+13
| +0% | +$1.02K |
|
503
Monster Beverage
MNST
$96.3B
| $2.94M | 0.01% |
248,208
-224,472
| -47% | -$2.56M |
|
|
CZZ
504
DELISTED
Cosan Limited
CZZ
| $2.94M | 0.01% |
216,603
+90,763
| +72% | +$1.16M |
|
505
Portland General Electric
POR
$5.89B
| $2.93M | 0.01% |
+84,438
| New | +$2.78M |
|
506
Palo Alto Networks
PANW
$257B
| $2.87M | 0.01% |
205,578
| – | – |
|
507
Consolidated Edison
ED
$41.5B
| $2.87M | 0.01% |
49,722
+30,800
| +163% | +$1.72M |
|
|
MFA
508
MFA Financial
MFA
$937M
| $2.86M | 0.01% |
+87,159
| New | +$2.82M |
|
|
RAI
509
DELISTED
Reynolds American Inc
RAI
| $2.85M | 0.01% |
94,664
-632
| -0.7% | -$18.1K |
|
|
PEI
510
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $2.85M | 0.01% |
10,087
+5,327
| +112% | +$1.41M |
|
|
TRF
511
DELISTED
TEMPLETON RUSSIA & EAST EURO FD
TRF
| $2.82M | 0.01% |
185,036
-31,680
| -15% | -$441K |
|
|
CYS
512
DELISTED
CYS Investments Inc.
CYS
| $2.79M | 0.01% |
+309,835
| New | +$2.74M |
|
513
Keurig Dr Pepper
KDP
$42.6B
| $2.73M | 0.01% |
46,532
-139,677
| -75% | -$7.85M |
|
514
American Homes 4 Rent
AMH
$12.1B
| $2.71M | 0.01% |
152,554
+109,800
| +257% | +$1.87M |
|
515
Northern Trust
NTRS
$22B
| $2.66M | 0.01% |
41,500
+40,000
| +2,667% | +$2.47M |
|
516
Hexcel
HXL
$7.89B
| $2.63M | 0.01% |
+64,195
| New | +$2.67M |
|
|
ROIC
517
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.62M | 0.01% |
166,636
+13,400
| +9% | +$210K |
|
518
GameStop
GME
$9.83B
| $2.61M | 0.01% |
+258,160
| New | +$2.53M |
|
|
LLL
519
DELISTED
L3 Technologies, Inc.
LLL
| $2.6M | 0.01% |
+21,500
| New | +$2.55M |
|
520
Crown Castle
CCI
$33.2B
| $2.6M | 0.01% |
34,955
| – | – |
|
521
Public Storage
PSA
$62.4B
| $2.57M | 0.01% |
14,995
| – | – |
|
|
TKF
522
DELISTED
Turkish Inv Fund
TKF
| $2.56M | 0.01% |
213,663
-19,442
| -8% | -$227K |
|
|
EXL
523
DELISTED
EXCEL TRUST , INC COM STK
EXL
| $2.48M | 0.01% |
186,000
| – | – |
|
|
TWO
524
Two Harbors Investment
TWO
$1.27B
| $2.46M | 0.01% |
+29,350
| New | +$2.44M |
|
525
Newmont
NEM
$93.9B
| $2.44M | 0.01% |
96,018
-3,000,755
| -97% | -$72.3M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.